189 related articles for article (PubMed ID: 15002360)
1. Using drug samples can hinder quality.
Healthcare Benchmarks Qual Improv; 2004 Mar; 11(3):34-5. PubMed ID: 15002360
[TBL] [Abstract][Full Text] [Related]
2. Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption.
Poser S
Food Drug Law J; 2007; 62(4):653-94. PubMed ID: 18557225
[No Abstract] [Full Text] [Related]
3. Drug samples: friend or foe?
Burkhart CG
J Drugs Dermatol; 2002 Sep; 1(2):123-4. PubMed ID: 12847733
[No Abstract] [Full Text] [Related]
4. Patient awareness and concern regarding pharmaceutical manufacturer interactions with doctors.
Edwards D; Ballantyne A
Intern Med J; 2009 Mar; 39(3):191-6. PubMed ID: 19383067
[TBL] [Abstract][Full Text] [Related]
5. Overdrugged patients: enough is enough.
Rapoport D
Can Fam Physician; 2002 Nov; 48():1764. PubMed ID: 12489240
[No Abstract] [Full Text] [Related]
6. Psychological motivations in physician prescribing habits.
Kalb CC
Med Mark Media; 1978 Oct; 13(10):43-5, 49-50, 52 passim. PubMed ID: 10238861
[No Abstract] [Full Text] [Related]
7. APhA activities. Fighting physician dispensing. A chronology.
Am Pharm; 1987 Oct; NS27(10):28-32. PubMed ID: 3687721
[No Abstract] [Full Text] [Related]
8. Allied against reform: pharmaceutical industry-academic physician relations in the United States, 1945-1970.
Tobbell DA
Bull Hist Med; 2008; 82(4):878-912. PubMed ID: 19075387
[TBL] [Abstract][Full Text] [Related]
9. Closing the sample closet.
Brown SR
Fam Pract Manag; 2006; 13(10):16; author reply 21. PubMed ID: 17139936
[No Abstract] [Full Text] [Related]
10. Is your sample cupboard relevant to your practice?
Spurling G; Kyle G
Aust Fam Physician; 2007 Mar; 36(3):187-8, 192. PubMed ID: 17339989
[TBL] [Abstract][Full Text] [Related]
11. Marketing in academic health centers.
Fisher SB
J Health Care Mark; 1986 Sep; 6(3):49-51. PubMed ID: 10301039
[No Abstract] [Full Text] [Related]
12. [Pharmaceutical economics and socialist organization science. Drug marketing series. Implication of marketing in the lapse of time in drug studies].
Alcer G
Pharm Prax; 1970; 8():169-73. PubMed ID: 5524906
[No Abstract] [Full Text] [Related]
13. Pharmacoepidemiology of antihypertensive drugs in primary care setting of Bahrain between 1998 and 2000.
Al Khaja KA; Sequeira RP
Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):741-8. PubMed ID: 16342299
[TBL] [Abstract][Full Text] [Related]
14. Samples: to use or not to use?
Daugherty KK
J Clin Pharm Ther; 2005 Dec; 30(6):505-10. PubMed ID: 16336281
[No Abstract] [Full Text] [Related]
15. Perceptions of the influence of prescription medicine samples on prescribing by family physicians.
Hall KB; Tett SE; Nissen LM
Med Care; 2006 Apr; 44(4):383-7. PubMed ID: 16565641
[TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical starter samples.
Teichman PG; Caffee AE
J Am Board Fam Pract; 2002; 15(6):509-10. PubMed ID: 12463302
[No Abstract] [Full Text] [Related]
17. Friction and fact in the marketing of pharmaceuticals and biologics.
Herrick JB
J Am Vet Med Assoc; 1992 Aug; 201(4):556-7. PubMed ID: 1517128
[No Abstract] [Full Text] [Related]
18. Drug sample availability and prescribing behavior.
Watts SA; Replogle WH; Noble SL; Beebe DK
J Am Board Fam Pract; 2002; 15(6):509. PubMed ID: 12463301
[No Abstract] [Full Text] [Related]
19. The pharmaceutical industry and academic medicine: opportunities for physician collaboration.
Jefferis JE
Circulation; 1985 Aug; 72(2 Pt 2):I21-4. PubMed ID: 3924438
[No Abstract] [Full Text] [Related]
20. Perception of prescription medicine sample packs among Australian professional, government, industry, and consumer organizations, based on automated textual analysis of one-on-one interviews.
Kyle GJ; Nissen L; Tett S
Clin Ther; 2008 Dec; 30(12):2461-73. PubMed ID: 19167604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
